Neurohormonal Activation in Congestive Heart Failure and the Role of Vasopressin
- 2 May 2005
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 95 (9), 8-13
- https://doi.org/10.1016/j.amjcard.2005.03.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Disorders of body water homeostasisBest Practice & Research Clinical Endocrinology & Metabolism, 2003
- Vasopressin receptor antagonists in heart failure.Current Opinion in Pharmacology, 2003
- Minireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine SystemEndocrinology, 2003
- Vasopressin Receptor AntagonistsAmerican Journal of Cardiovascular Drugs, 2003
- New Therapeutic Options in Congestive Heart Failure: Part ICirculation, 2002
- Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressinCardiovascular Research, 2001
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous systemJournal of the American College of Cardiology, 1986
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982